Chemokine expression is upregulated in chondrocytes in diabetic fracture healing

Bone

Volumn 53, Issue 1, 2013, Pages 294-300

  Alblowi, Jazia ^a   Tian, Chen ^b   Siqueira, Michelle F ^c   Kayal, Rayyan A ^a   McKenzie, Erin ^c   Behl, Yugal ^c   Gerstenfeld, Louis ^d   Einhorn, Thomas A ^d   Graves, Dana T ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Cytokine; Fracture healing; Inflammation; TNF

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CXCL2 CHEMOKINE; EOTAXIN; EOTAXIN 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; CALLUS; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMUR FRACTURE; FRACTURE HEALING; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYME CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; CHEMOKINES; CHONDROCYTES; DIABETES MELLITUS, EXPERIMENTAL; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; MICE; RNA INTERFERENCE; RNA, MESSENGER; UP-REGULATION;

EID: 84872409354     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.12.006     Document Type: Article

References (36)

1. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci 2009, 14:540-551.
2. Bendre M.S., Montague D.C., Peery T., Akel N.S., Gaddy D., Suva L.J. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003, 33:28-37.
3. Wright L.M., Maloney W., Yu X., Kindle L., Collin-Osdoby P., Osdoby P. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 2005, 36:840-853.
4. Silva T.A., Garlet G.P., Fukada S.Y., Silva J.S., Cunha F.Q. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007, 86:306-319.
5. Giuliani N., Lisignoli G., Colla S., Lazzaretti M., Storti P., Mancini C., et al. CC-Chemokine ligand 20/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res 2008, 68:6840-6850.
6. Maruotti N., Grano M., Colucci S., d'Onofrio F., Cantatore F.P. Osteoclastogenesis and arthritis. Clin Exp Med 2011, 11:137-145.
7. Repeke C.E., Ferreira S.B., Claudino M., Silveira E.M., de Assis G.F., Avila-Campos M.J., et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 2010, 46:1122-1130.
8. Haaber J., Abildgaard N., Knudsen L.M., Dahl I.M., Lodahl M., Thomassen M., et al. Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. Br J Haematol 2008, 140:25-35.
9. Roodman G.D. Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer 1997, 80:1557-1563.
10. Kabashima H., Yoneda M., Nagata K., Hirofuji T., Ishihara Y., Yamashita M., et al. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. Cytokine 2001, 16:62-66.
11. Frisch B.J., Ashton J.M., Xing L., Becker M.W., Jordan C.T., Calvi L.M. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 2012, 119:540-550.
12. Kim M.S., Day C.J., Selinger C.I., Magno C.L., Stephens S.R., Morrison N.A. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 2006, 281:1274-1285.
13. Grassi F., Cristino S., Toneguzzi S., Piacentini A., Facchini A., Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 2004, 199:244-251.
14. Kayal R.A., Tsatsas D., Bauer M.A., Allen B., Al-Sebaei M.O., Kakar S., et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 2007, 22:560-568.
15. Kayal R.A., Siqueira M., Alblowi J., McLean J., Krothapalli N., Faibish D., et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis Through FOXO1. J Bone Miner Res 2010, 25:1604-1615.
16. Alblowi J., Kayal R.A., Siqueria M., McKenzie E., Krothapalli N., McLean J., et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 2009, 175:1574-1585.
17. Kayal R.A., Alblowi J., McKenzie E., Krothapalli N., Silkman L., Gerstenfeld L., et al. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 2009, 44:357-363.
18. Gerstenfeld L.C., Wronski T.J., Hollinger J.O., Einhorn T.A. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res 2005, 20:1715-1722.
19. Gerstenfeld L.C., Alkhiary Y.M., Krall E.A., Nicholls F.H., Stapleton S.N., Fitch J.L., et al. Three-dimensional reconstruction of fracture callus morphogenesis. J Histochem Cytochem 2006, 54:1215-1228.
20. Wang K., Vishwanath P., Eichler G.S., Al-Sebaei M.O., Edgar C.M., Einhorn T.A., et al. Analysis of fracture healing by large-scale transcriptional profile identified temporal relationships between metalloproteinase and ADAMTS mRNA expression. Matrix Biol 2006, 25:271-281.
21. Abe M., Hiura K., Wilde J., Moriyama K., Hashimoto T., Ozaki S., et al. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 2002, 100:2195-2202.
22. Han J.H., Choi S.J., Kurihara N., Koide M., Oba Y., Roodman G.D. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 2001, 97:3349-3353.
23. Ramaswamy S., Nakamura N., Sansal I., Bergeron L., Sellers W.R. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002, 2:81-91.
24. Loder R. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop 1988, 232:210-216. (Review).
25. Herbsman H., Powers J., Hirschman A., Shaftan G. Retardation of fracture healing in experimental diabetes. J Surg Res 1968, 8:424-431.
26. Szekanecz Z., Vegvari A., Szabo Z., Koch A.E. Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed) 2010, 2:153-167.
27. Kasama T., Strieter R.M., Lukacs N.W., Lincoln P.M., Burdick M.D., Kunkel S.L. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995, 95:2868-2876.
28. Sandell L.J., Xing X., Franz C., Davies S., Chang L.W., Patra D. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage 2008, 16:1560-1571.
29. Silvestri T., Meliconi R., Pulsatelli L., Dolzani P., Zizzi F., Frizziero L., et al. Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. Rheumatology (Oxford) 2003, 42:14-18.
30. Djouad F., Delorme B., Maurice M., Bony C., Apparailly F., Louis-Plence P., et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007, 9:R33.
31. Ogasawara A., Nakajima A., Nakajima F., Goto K., Yamazaki M. Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone 2008, 43:832-839.
32. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Tsay A., Fitch J., et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 2003, 18:1584-1592.
33. James C.G., Appleton C.T., Ulici V., Underhill T.M., Beier F. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol Biol Cell 2005, 16:5316-5333.
34. Borzi R.M., Mazzetti I., Macor S., Silvestri T., Bassi A., Cattini L., et al. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett 1999, 455:238-242.
35. Vergunst C.E., van de Sande M.G., Lebre M.C., Tak P.P. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005, 34:415-425.
36. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23:471-478.